David Ojcius – Microbiology Research News and Articles

Ivermectin is widely used to treat parasitic infections, but its effects on bacterial pathogens have remained largely unexplored. This study demonstrates that ivermectin inhibits infection and growth of Chlamydia trachomatis in epithelial cells. The findings reveal a previously unrecognized antibacterial activity and suggest that clinically achievable doses may have therapeutic potential for sexually transmitted and ocular chlamydial infections.

Using genome mining, transcriptomics, and untargeted metabolomics, this study investigated how N-acetylglucosamine influences secondary metabolism in Actinokineospora bangkokensis 44EHWT. Supplementation induced hundreds of unique metabolites, increased thailandin B abundance, improved crude extract yield by 25.92%, and enhanced antifungal activity against anthracnose pathogens, revealing selective pathway activation.

Growing evidence suggests that periodontal pathogens may influence health far beyond the oral cavity. Bacteria associated with periodontitis and their metabolic products can trigger immune and inflammatory responses linked to cardiovascular disease, diabetes, colorectal cancer, respiratory infections, adverse pregnancy outcomes, and Alzheimer's disease. While causality remains uncertain, oral microbes may play an important role in systemic health.

Oral health care is undergoing rapid transformation as advances in medicine and digital technologies reshape disease prevention, diagnosis, and treatment. Growing recognition of the relationship between oral and systemic health is driving closer integration of dental and medical care. Emerging innovations in artificial intelligence, robotics, genomics, and novel antimicrobials promise more precise and personalized care.

Researchers exploited the modular architecture of bacterial phage defense systems to identify new antiviral mechanisms in Pseudomonas aeruginosa . By tracking defense-associated components across different genetic contexts, they uncovered a large network of candidate systems. Experimental validation confirmed three new defenses, providing a powerful strategy for discovering bacterial immunity mechanisms.

Nitrogen availability is critical for mycobacterial survival, yet its regulation remains incompletely understood. This study identifies the response regulator MtrA as a key modulator of the GlnR-controlled nitrogen regulon in Mycobacterium smegmatis . Transcriptomic, biochemical, and physiological analyses showed that MtrA both activates and represses distinct gene sets, helping coordinate nutrient use and metabolic balance.